Share this post on:

Product Name :
RT103(Regel Therapeutics)

Search keywords :
SynGAP

drugId :
null

Target Vo:
Ras/Rap GTPase-activating protein SynGAP

Target Vo Short Name :
SYNGAP1

Moa_Name:
Gene expression modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regel Therapeutics

Active Company_Name :
Regel Therapeutics

Active Indication_Name:
Central Nervous System Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ASC Rabbit pAb medchemexpress
mTOR Rabbit mAb Cancer
KMT6/EZH2 Antibody: KMT6/EZH2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to KMT6/EZH2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Share this post on:

Author: Betaine hydrochloride